Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dengue virus type 4 (DENV-4) is one of four antigenically distinct serotypes of the dengue virus, which belongs to the genus *Flavivirus* in the family *Flaviviridae*. Like other dengue viruses, DENV-4 is a single-stranded, positive-sense RNA virus. It is a causative agent of dengue fever and can also contribute to more severe forms such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), though it has historically been less frequently associated with severe disease compared to some other serotypes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dengue Virus Type 4 (DENV-4).